Pelvic sling devices and transvaginal mesh products manufactured by CR Bard are among several different brands that have been implanted in thousands of women during gynecological procedures to repair two serious conditions: stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Unfortunately, many CR Bard mesh products have been linked to an increased rate of complications, leaving many patients to cope with disability and permanent pain. Women across the U.S. have filed pelvic mesh and transvaginal mesh lawsuits against CR Bard and are seeking compensation for serious injuries and complications, including chronic infection, vaginal bleeding, perforation of organs and extrusion and erosion of mesh as well as emotional distress and pain.
If you or a woman you love experienced pain, infections, erosion or other adverse side effects while fitted with a transvaginal mesh device, contact Bernstein Liebhard LLP today to learn more about your legal rights and how to file your own lawsuit to seek compensation for your condition and hold the manufacturer accountable for your injuries.
Transvaginal Mesh Used for POP and SUI
Several transvaginal mesh products manufactured by CR Bard have been named in lawsuits across the U.S., including:
- Pelvicol Acellular Collagen Matrix
- Pelvisoft BioMesh
Following a hysterectomy, pregnancy or childbirth, some women may experience weakened pelvic muscles. These devices are designed to treat the symptoms of the ensuing conditions, POP and SUI, in which the organs can fall into the vaginal cavity. Implanting a transvaginal mesh device into the pelvis can provide increased support to assist the body in holding the rectum, uterus and bladder in place.
CR Bard Mesh Products May Cause Serious Injuries
According to the U.S. Food and Drug Administration (FDA), the most common complications of transvaginal mesh devices include:
- Urinary problems
- Organ perforation
- Pain during intercourse
- Mesh erosion
Additionally, the agency reportedly received over 1,000 adverse event claims from patients between 2005 and 2007. Between 2008 and 2011, that number increased to over 2,800 claims, prompting the agency to issue a warning to inform CR Bard and other manufacturers that they would be required to conduct post-market trials to study whether their transvaginal mesh products were effective and safe before releasing them to consumers.
Transvaginal Mesh Recalls and Litigation
The FDA issued a Public Health Notification in October 2008, prompting calls for a CR Bard mesh recall. The document advised health practitioners and consumers of the serious complications associated with transvaginal placement of surgical mesh. Although CRD Bard did subsequently suspend sales of Avaulta products, it was not considered a recall because those devices that had previously been sold were not pulled.
According to plaintiffs, CR Bard mesh devices were defectively designed and caused serious complications and injuries. The lawsuits also allege that the manufacturer knew that its products were harmful to women but neglected to warn the public in an effort to protect itself. If women develop serious complications due to mesh insertion, they will most likely need to have the device removed – a process that could involve several revision procedures and subsequent repair of the prolapse that required the procedure in the first place.
These treatments can be expensive, painful and time-consuming as some women experience more severe complications such as damage to organs near the site of insertion. None of these issues would have existed if the transvaginal mesh devices were safe to use. Therefore, women have good cause to take legal action and file a lawsuit against the manufacturer.
According to court documents, over 40,000 claims are pending from those who have allegedly experienced side effects due to transvaginal mesh products. The majority of these lawsuits are pending in individual multidistrict litigations in the U.S. District Court, Southern District of West Virginia.
There have been two CR Bard mesh lawsuit settlements to date, the first of which was settled in July 2012 in California state court. This was the country’s first trial involving CR Bard and ended with a $5.5 million settlement for the plaintiff and her husband. The second trial was settled in August 2013 when CR Bard was ordered to pay $2 million to the plaintiff who had alleged in her claim that the manufacturer hid flaws of its implants.
Bernstein Liebhard LLP Can Fight for Your Legal Rights
If you or a loved one has experienced one or more serious side effects associated with CR Bard mesh products, contact the attorneys at Bernstein Liebhard LLP today by filling out the form on this page or calling us at (888) 217-3033 for a free, confidential case evaluation. We will review the circumstances surrounding your mesh complications and injuries and help you to determine if you are eligible to file a claim.